Skip to content
Screener

Discontinued — last reported Q2 '26

EPS (Diluted) at other companies

Veradermics logo
VeradermicsMANE
-$1.32+93.3%
BK
BKBK
$2.24+41.8%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$0.05+54.5%
Schering-Plough logo
Schering-PloughSGP
-$0.69+82.6%
Dycom Industries logo
Dycom IndustriesDY
$3.00+43.5%
Target logo
TargetTGT
$1.71-24.7%

Other financials

Income statement

See full
Revenue$1.2B+30.0%
Gross profit$1.1B+23.1%
Operating income$526.7M+18.5%
Net income$403.6M+18.1%

Balance sheet

See full
Cash & equivalents$104.8M-19.2%
Total debt$9.1B+30.4%
Total assets$16.3B+34.2%

Cash flow

See full
Operating cash flow$534.7M-5.2%
CapEx$270.3M+51.3%
Free cash flow$264.4M-31.4%

Valuation

See full
Market cap$19.07B+24.0%
Enterprise value$28.09B+26.3%
P/E14.9×+2.8×
P/S4.4×+0.2×

Profitability

See full
Gross margin92.1%-3.7pp
Operating margin40.2%-5.4pp
Net margin29.6%-5.0pp
FCF margin28.1%-11.4pp

Returns & leverage

See full
Current ratio0.9×-0.4×

Where this comes from

Reported directly by Western Midstream Partners in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted.

The source filing: Western Midstream Partners’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001423902-26-000093
thousands except per-unit amountsThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Limited partners’ interest in net income (loss):
Net income (loss) attributable to Western Midstream Partners, LP$403,552$341,680$753,828$650,687
General partner interest in net (income) loss(8,668)(7,930)(16,554)(15,100)
Limited partners’ interest in net income (loss) (4)394,884333,750737,274635,587
Net income (loss) per common unit – basic (4)$0.99$0.88$1.85$1.67
Net income (loss) per common unit – diluted (4)$0.99$0.87$1.84$1.66
Weighted-average common units outstanding – basic (4)398,043381,328398,566381,158
Weighted-average common units outstanding – diluted (4)399,381382,326400,030382,398

Item 1. Financial Statements

FAQ

What is Western Midstream Partners's EPS (diluted)?
Western Midstream Partners (WES) reported EPS (diluted) of $0.99 in Q2 2026.
How has Western Midstream Partners's EPS (diluted) changed year-over-year?
Western Midstream Partners's EPS (diluted) increased by 13.8% year-over-year, from $0.87 to $0.99.
What is the long-term trend for Western Midstream Partners's EPS (diluted)?
Over 4 years (2021 to 2025), Western Midstream Partners's EPS (diluted) has grown at a 8.0% compound annual growth rate (CAGR), from $2.19 to $2.98.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Western Midstream Partners's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude